Regeneron Pharmaceuticals (REGN.VI) Q3 2020 Earnings

5AugConfirmed
Q4 2019
Q1 2020
Q2 2020
Q3 2020
4.83
5.49
6.16
6.83

Details

Expected EPS
4.8256914
Actual EPS
6.0300088
Surprise EPS
1.2
Surprise Percent
+24.96%

Description

Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 6.0300088 per share for Q3 2020.

0 Comments

Share your thoughts